Our patent portfolio exemplifies our belief in improving the assessment of high-risk medical conditions and diseases through the identification and validation of protein biomarkers. We have assembled an experienced team of scientists dedicated to providing innovative products that serve the needs of our customers.

Through this innovation, we continue to develop a portfolio of patent applications in various disease fields. Our intellectual properties include an estate of more than 30 published international patent applications, a list of which may be found here. Our patent applications have been filed in major geographic regions including the United States, Canada, Japan, China, India, and the European Union.

Our Brand Names

Astute Medical® and the “AM” logo

Astute Medical® is dedicated to improving the assessment of high-risk medical conditions and diseases through the identification and validation of protein biomarkers that can serve as the basis for novel diagnostic tests. The Company’s focus is community and hospital acquired acute conditions that require rapid diagnosis and risk assessment. Astute Medical’s current areas of interest include abdominal pain, acute coronary syndromes, cerebrovascular injury, kidney injury and sepsis.